Literature DB >> 28539760

Neuro and intraocular cysticercosis: A clinicopathological case report.

Dipankar Das1, Satyen Deka1, Saidul Islam2, Nilutparna Deuri1, Panna Deka1, Akshay Chandra Deka1, Hemalata Deka1, Sanjoy Kumar Buragohain1, Harsha Bhattacharjee1.   

Abstract

Cysticercosis is one of the most common parasitic infestations in humans. Neurocysticercosis (NCC) is the commonest parasitosis of the central nervous system (CNS), endemic in developing countries and is also seen in developed nations with high rates of immigration from prevalent areas. Co-infection of ocular tissue is also significant and often ophthalmologists come across these lesions in their clinical practice. The mode of treatment in NCC and that of intraocular cysticercosis is somewhat different as far as antiparasitic treatment is concerned. This case report highlights the proper management of this parasitic infestation which involved both eye and brain.

Entities:  

Keywords:  corticosteroid; endemic; neurocysticercosis; scolex

Year:  2010        PMID: 28539760      PMCID: PMC5436174     

Source DB:  PubMed          Journal:  Eye Brain        ISSN: 1179-2744


  14 in total

1.  Simultaneous ocular and systemic cysticercosis and tuberculosis.

Authors:  A Rani; N Pushker; A Kulkarni; R Balasubramanya; M S Bajaj
Journal:  Infection       Date:  2006-06       Impact factor: 3.553

2.  Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis.

Authors:  Arturo Carpio; W Allen Hauser
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

3.  The successful removal of a subretinal cysticercus by pars plana vitrectomy.

Authors:  R L Steinmetz; S Masket; Y Sidikaro
Journal:  Retina       Date:  1989       Impact factor: 4.256

4.  Simultaneous intraocular and bilateral extraocular muscle involvement in a case of disseminated cysticercosis.

Authors:  Vikas Chadha; P K Pandey; Depender Chauhan; Sima Das
Journal:  Int Ophthalmol       Date:  2006-06-15       Impact factor: 2.031

5.  Magnitude of the disease burden from neurocysticercosis in a developing country.

Authors:  C Bern; H H Garcia; C Evans; A E Gonzalez; M Verastegui; V C Tsang; R H Gilman
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

6.  A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis.

Authors:  Héctor H Garcia; E Javier Pretell; Robert H Gilman; S Manuel Martinez; Lawrence H Moulton; Oscar H Del Brutto; Genaro Herrera; Carlton A W Evans; Armando E Gonzalez
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

7.  Intraocular cysticercosis: clinical characteristics and visual outcome after vitreoretinal surgery.

Authors:  Tarun Sharma; Sourav Sinha; Nitant Shah; Lingam Gopal; Mahesh P Shanmugam; Pramod Bhende; Muna Bhende; Nitin S Shetty; Rajat Agrawal; Dhanashree Deshpande; Jyotirmay Biswas; B Sukumar
Journal:  Ophthalmology       Date:  2003-05       Impact factor: 12.079

8.  Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial.

Authors:  A Carpio; E A Kelvin; E Bagiella; D Leslie; P Leon; H Andrews; W A Hauser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-05-21       Impact factor: 10.154

9.  Recommendations of the International Task Force for Disease Eradication.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1993-12-31

10.  Atypical ophthalmological presentation of neurocysticercosis in two children.

Authors:  Jitendra Jethani; P Vijayalakshmi; Mahesh Kumar
Journal:  J AAPOS       Date:  2007-07-19       Impact factor: 1.220

View more
  2 in total

1.  Clinicopathological study of parasitic lesions of the eye and ocular adnexa in a tertiary care ophthalmic center in South India.

Authors:  Meenakshi Mahesh; Marian Pauly; Shruthi M Krishna; M Raman; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

2.  Ocular cysticercosis in a 32-year-old man in Abuja: ultrasonic features as an aid in diagnosis.

Authors:  Oe Babalola; A Adu; Ao Akano
Journal:  Clin Ophthalmol       Date:  2013-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.